IMAGE

Fig. 5

ID
ZDB-IMAGE-210514-12
Source
Figures for Benson et al., 2021
Image
Figure Caption

Fig. 5 Compound 15 selectively ablates human glioblastoma cancer cells under clinical PDT conditions and in the presence of non-cancerous human brain cells.

a Procedure for coculturing human non-cancerous brain HCN-2 cells (stained with CellMask Green) and human glioblastoma U87-nlsCrimson cells. Cocultures (15,000 HCN-2 cells and 10,000 U87 cells per well) were incubated with compound 15 (100 μM) and illuminated with ThorLabs M530L3 LED (37 J cm−2). The fluorescence emission from E2Crimson is reduced in U87-nlsCrimson glioblastoma cells upon cell death. (b, c) Representative brightfield and fluorescent confocal microscopy images (from three independent experiments) of cocultured HCN-2 (green, λem: 520 nm) and U87-nlsCrimson (magenta, λem: 645 nm) before (b) and after treatment (c). Yellow arrowheads in (c) highlight dead U87h cells devoid of Crimson fluorescence. Scale bars: 10 μm. d Phototoxicity analysis under different concentrations of compound 15 and 5-ALA in U87 glioblastoma cells (20,000 cells/well) using the same irradiation settings (10 mW, 37 J cm−2). Data presented as mean values ± SEM (n = 3 independent experiments). e HCN-2 cell viability (10,000 cells/well) after incubation with concentrations under the phototoxicity threshold [i.e., compound 15 (100 μM, red) and 5-ALA (200 μM, blue)] and light exposure (37 J cm−2). Data presented as mean values ± SEM (n = 4 independent experiments). Source data are available.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Nat. Commun.